These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 27866092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
    Liu YR, Jiang YZ, Yu KD, Shao ZM.
    Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
    [Abstract] [Full Text] [Related]

  • 7. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R.
    J Clin Oncol; 2006 Feb 20; 24(6):872-7. PubMed ID: 16484696
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers.
    Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G, Coates AS, Viale G, Sapino A.
    Breast Cancer Res Treat; 2010 Dec 20; 124(3):607-17. PubMed ID: 20127405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
    Shen X, Anne PR, Keith SW, Wojcieszynski A, Mishra MV, Bar-Ad V, Showalter TN.
    Am J Clin Oncol; 2014 Jun 20; 37(3):241-7. PubMed ID: 23241502
    [Abstract] [Full Text] [Related]

  • 15. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer.
    Leone J, Hassett MJ, Freedman RA, Tolaney SM, Graham N, Tayob N, Vallejo CT, Winer EP, Lin NU, Leone JP.
    JAMA Oncol; 2024 Apr 01; 10(4):508-515. PubMed ID: 38421673
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.
    Jatoi I, Chen BE, Anderson WF, Rosenberg PS.
    J Clin Oncol; 2007 May 01; 25(13):1683-90. PubMed ID: 17404367
    [Abstract] [Full Text] [Related]

  • 19. Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.
    Anderson WF, Chen BE, Jatoi I, Rosenberg PS.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):121-6. PubMed ID: 16685588
    [Abstract] [Full Text] [Related]

  • 20. Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).
    Inal A, Akman T, Yaman S, Demir Ozturk S, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Yesil Cinkir H, Alici S, Uysal Sonmez O, Goksel G, Gokoz Dogu G, Umit Unal O, Tamozlu T, Buyukberber S, Melih Boruban C, Isikdogan A.
    J BUON; 2013 Nov 01; 18(1):64-9. PubMed ID: 23613390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.